(Q50113046)

25 February 2018

title

Gene delivery by attenuated Salmonella typhimurium: comparing the efficacy of helper versus cytotoxic T cell priming in tumor vaccination. (English)

1 reference

25 February 2018

main subject

cytotoxicity

0 references

Salmonella Typhimurium

1 reference

Weth R

1

1 reference

25 February 2018

Christ O

series ordinal

2

1 reference

25 February 2018

Stevanovic S

series ordinal

3

1 reference

25 February 2018

Zöller M

series ordinal

4

1 reference

25 February 2018

publication date

1 August 2001

1 reference

25 February 2018

published in

Cancer Gene Therapy

1 reference

25 February 2018

volume

8

1 reference

25 February 2018

issue

8

1 reference

25 February 2018

page(s)

599-611

1 reference

25 February 2018

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7700352

exact match

0 references

cites work

Tumor antigens recognized by T lymphocytes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700352

7 January 2021

Immunology and immunotherapy of human cancer: present concepts and clinical developments

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700352

7 January 2021

Cloning, expression and tissue distribution of the murine homologue of the melanocyte lineage-specific antigen gp100.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700352

7 January 2021

Analysis of Pmel17/gp100 expression in primary human tissue specimens: implications for melanoma immuno- and gene-therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700352

7 January 2021

Cytolytic T cell reactivity against melanoma-associated differentiation antigens in peripheral blood of melanoma patients and healthy individuals

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700352

7 January 2021

Immunobiology of human melanoma antigens MART-1 and gp100 and their use for immuno-gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700352

7 January 2021

Vaccination with a recombinant vaccinia virus encoding a "self" antigen induces autoimmune vitiligo and tumor cell destruction in mice: requirement for CD4(+) T lymphocytes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700352

7 January 2021

New cancer therapy by immunomanipulation: development of immunotherapy for human melanoma as a model system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700352

7 January 2021

New treatment options for patients with melanoma: review of melanoma-derived T-cell epitope-based peptide vaccines.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700352

7 January 2021

Granulocyte-macrophage-colony-stimulating factor enhances immune responses to melanoma-associated peptides in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700352

7 January 2021

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700352

7 January 2021

Murine dendritic cells transfected with human GP100 elicit both antigen-specific CD8(+) and CD4(+) T-cell responses and are more effective than DNA vaccines at generating anti-tumor immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700352

7 January 2021

gp100/pmel 17 is a murine tumor rejection antigen: induction of "self"-reactive, tumoricidal T cells using high-affinity, altered peptide ligand

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700352

7 January 2021

Cloning and characterization of the genes encoding the murine homologues of the human melanoma antigens MART1 and gp100

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700352

7 January 2021

An autologous oral DNA vaccine protects against murine melanoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700352

7 January 2021

Dendritic cell vaccines for cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700352

7 January 2021

Cellular and humoral immune responses in patients with metastatic renal cell carcinoma after vaccination with antigen pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700352

7 January 2021

Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700352

7 January 2021

T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700352

7 January 2021

Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700352

7 January 2021

Help for cytotoxic-T-cell responses is mediated by CD40 signalling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700352

7 January 2021

The central role of CD4(+) T cells in the antitumor immune response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700352

7 January 2021

Tumor-specific CD4+ T lymphocytes from cancer patients are required for optimal induction of cytotoxic T cells against the autologous tumor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700352

7 January 2021

Dendritic cells, interleukin 12, and CD4+ lymphocytes in the initiation of class I-restricted reactivity to a tumor/self peptide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700352

7 January 2021

Studies in listeriosis show the strong symbiosis between the innate cellular system and the T-cell response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700352

7 January 2021

Induction of TH1 and TH2 responses: a key role for the 'natural' immune response?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700352

7 January 2021

Immunotherapy of cancer with dendritic-cell-based vaccines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700352

7 January 2021

RNA melanoma vaccine: induction of antitumor immunity by human glycoprotein 100 mRNA immunization.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700352

7 January 2021

DNA and RNA-based vaccines: principles, progress and prospects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700352

7 January 2021

DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700352

7 January 2021

Control of immune responses by gene immunization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700352

7 January 2021

Live attenuated Salmonella: a paradigm of mucosal vaccines.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700352

7 January 2021

Oral somatic transgene vaccination using attenuated S. typhimurium.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700352

7 January 2021

The defined attenuated Listeria monocytogenes delta mp12 mutant is an effective oral vaccine carrier to trigger a long-lasting immune response against a mouse fibrosarcoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700352

7 January 2021

Sorting signals in the MHC class II invariant chain cytoplasmic tail and transmembrane region determine trafficking to an endocytic processing compartment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700352

7 January 2021

Expression of endogenous peptide-major histocompatibility complex class II complexes derived from invariant chain-antigen fusion proteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700352

7 January 2021

MHC class II-associated invariant chain peptide replacement by T cell epitopes: engineered invariant chain as a vehicle for directed and enhanced MHC class II antigen processing and presentation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700352

7 January 2021

C-terminal extension of the MHC class II-associated invariant chain by an antigenic sequence triggers activation of naive T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700352

7 January 2021

Alloreactive cytolytic T-cell clones preferentially recognize conformational determinants on histocompatibility antigens: analysis with genetically engineered hybrid antigens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700352

7 January 2021

Cross-blocking studies with monoclonal antibodies against I-A molecules of haplotypes b, d and k

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700352

7 January 2021

Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700352

7 January 2021

Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700352

7 January 2021

SYFPEITHI: database for MHC ligands and peptide motifs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700352

7 January 2021

The JAM test. A simple assay for DNA fragmentation and cell death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700352

7 January 2021

Dendritic cell-based genetic immunization in mice with a recombinant adenovirus encoding murine TRP2 induces effective anti-melanoma immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700352

7 January 2021

Dendritic cells infected with a vaccinia vector carrying the human gp100 gene simultaneously present multiple specificities and elicit high-affinity T cells reactive to multiple epitopes and restricted by HLA-A2 and -A3.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700352

7 January 2021

CIIV, MIIC and other compartments for MHC class II loading

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700352

7 January 2021

Identification of a MHC class II-restricted human gp100 epitope using DR4-IE transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700352

7 January 2021

Melanoma cells present a MAGE-3 epitope to CD4(+) cytotoxic T cells in association with histocompatibility leukocyte antigen DR11.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700352

7 January 2021

Melan-A/MART-1(51-73) represents an immunogenic HLA-DR4-restricted epitope recognized by melanoma-reactive CD4(+) T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700352

7 January 2021

In vitro and in vivo induction of a Th cell response toward peptides of the melanoma-associated glycoprotein 100 protein selected by the TEPITOPE program

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700352

7 January 2021

Recombinant gp100 protein presented by dendritic cells elicits a T-helper-cell response in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700352

7 January 2021

Prophylactic tumor vaccination: comparison of effector mechanisms initiated by protein versus DNA vaccination.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700352

7 January 2021

The selective engulfment of apoptotic bodies by dendritic cells is mediated by the alpha(v)beta3 integrin and requires intracellular and extracellular calcium

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700352

7 January 2021

Inverse relationship of melanocyte differentiation antigen expression in melanoma tissues and CD8+ cytotoxic-T-cell responses: evidence for immunoselection of antigen-loss variants in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700352

7 January 2021

The role of CTLA-4 in the regulation of T cell immune responses.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700352

7 January 2021

Identifiers

DOI

10.1038/SJ.CGT.7700352

1 reference

25 February 2018

1 reference

25 February 2018